Comparison · NCT03941834-e26ed3c1
DBT Phase: Pooled Rimegepant vs DBT Phase: Pooled Placebo: Number of Participants With Any Change From Baseline in Sheehan Suicidality Tracking Scale (S-STS) Scores: DBT Phase
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. DBT Phase: Pooled Rimegepant vs DBT Phase: Pooled Placebo: Number of Participants With Any Change From Baseline in Sheehan Suicidality Tracking Scale (S-STS) Scores: DBT Phase. Trial comparisons, record NCT03941834-e26ed3c1. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT03941834-e26ed3c1
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0 | 0.0000000000000000139 | 0.121 | wilson | |
| Risk in group 2 | 0 | 0 | 0.117 | wilson | |
| Risk difference, group 1 minus group 2 | 0 | -0.117 | 0.121 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | log | a group has no participants with the outcome | |||
| Odds ratio, group 1 over group 2 | log | a cell of the two-by-two table is zero | |||
| Number needed to treat | from the risk difference interval | the two groups' risks are equal |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | DBT Phase: Pooled Rimegepant | Participants who received rimegepant 75 mg IR tablet in treatment period 1 or 2 of DBT phase. | 0 | 28 | OG000 |
| Group 2 | DBT Phase: Pooled Placebo | Participants who received placebo matched to rimegepant in treatment period 1 or 2 of DBT phase. | 0 | 29 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Any Change From Baseline in Sheehan Suicidality Tracking Scale (S-STS) Scores: DBT Phase
- Description
S-STS is a scale that assesses the seriousness of suicidality phenomena on a 5-point Likert-type scale (0 to 4) ranging from not at all (0) to extremely (4), where higher scores signify suicidal tendency. In this outcome measure, number of participants who had any change in S-STS score from baseline to end of treatment are reported according to the treatment received in first or second treatment period of DBT phase.
- Time frame
- DBT Phase: Baseline, 2 Weeks Treatment
- Population
DBT treated set consisted of participants in the treated analysis set who took \>= 1 dose of DB study drug (rimegepant or placebo), i.e., non-missing study drug start date. Here, Number of Participants Analyzed signifies number of participants in DBT treated set, per treatment (pooled) received either in first or second treatment period of DBT phase.
Source ClinicalTrials.gov
Trial
- Title
- Trial for Treatment Refractory Trigeminal Neuralgia
- NCT number
- NCT03941834
- Phases
- PHASE2
- Conditions
- Trigeminal Neuralgia
- Interventions
- Rimegepant, Placebo
- Lead sponsor
- Pfizer
- Results first posted
- 2024-06-10
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT03941834?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT03941834-e26ed3c1